These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 26577496)
1. Hydroxytyrosol, a product from olive oil, reduces colon cancer growth by enhancing epidermal growth factor receptor degradation. Terzuoli E; Giachetti A; Ziche M; Donnini S Mol Nutr Food Res; 2016 Mar; 60(3):519-29. PubMed ID: 26577496 [TBL] [Abstract][Full Text] [Related]
2. Sulindac metabolites induce proteosomal and lysosomal degradation of the epidermal growth factor receptor. Pangburn HA; Ahnen DJ; Rice PL Cancer Prev Res (Phila); 2010 Apr; 3(4):560-72. PubMed ID: 20332299 [TBL] [Abstract][Full Text] [Related]
3. Hydroxytyrosol inhibits the proliferation of human colon adenocarcinoma cells through inhibition of ERK1/2 and cyclin D1. Corona G; Deiana M; Incani A; Vauzour D; Dessì MA; Spencer JP Mol Nutr Food Res; 2009 Jul; 53(7):897-903. PubMed ID: 19685549 [TBL] [Abstract][Full Text] [Related]
4. Hydroxytyrosol and the Colonic Metabolites Derived from Virgin Olive Oil Intake Induce Cell Cycle Arrest and Apoptosis in Colon Cancer Cells. López de Las Hazas MC; Piñol C; Macià A; Motilva MJ J Agric Food Chem; 2017 Aug; 65(31):6467-6476. PubMed ID: 28071050 [TBL] [Abstract][Full Text] [Related]
5. Hydroxytyrosol induces apoptosis in human colon cancer cells through ROS generation. Sun L; Luo C; Liu J Food Funct; 2014 Aug; 5(8):1909-14. PubMed ID: 24953710 [TBL] [Abstract][Full Text] [Related]
6. Dual inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation by AEE788 reduces growth and metastasis of human colon carcinoma in an orthotopic nude mouse model. Yokoi K; Thaker PH; Yazici S; Rebhun RR; Nam DH; He J; Kim SJ; Abbruzzese JL; Hamilton SR; Fidler IJ Cancer Res; 2005 May; 65(9):3716-25. PubMed ID: 15867367 [TBL] [Abstract][Full Text] [Related]
7. Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells. Park JJ; Yi JY; Jin YB; Lee YJ; Lee JS; Lee YS; Ko YG; Lee M Biochem Pharmacol; 2012 Apr; 83(7):849-57. PubMed ID: 22266356 [TBL] [Abstract][Full Text] [Related]
8. Tephrosin induces internalization and degradation of EGFR and ErbB2 in HT-29 human colon cancer cells. Choi S; Choi Y; Dat NT; Hwangbo C; Lee JJ; Lee JH Cancer Lett; 2010 Jul; 293(1):23-30. PubMed ID: 20056314 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of hypoxia inducible factor-1alpha by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E synthase-1/vascular endothelial growth factor expression and reduces tumor angiogenesis. Terzuoli E; Donnini S; Giachetti A; Iñiguez MA; Fresno M; Melillo G; Ziche M Clin Cancer Res; 2010 Aug; 16(16):4207-16. PubMed ID: 20682710 [TBL] [Abstract][Full Text] [Related]
10. Oleuropein, a secoiridoid derived from olive tree, inhibits the proliferation of human colorectal cancer cell through downregulation of HIF-1α. Cárdeno A; Sánchez-Hidalgo M; Rosillo MA; Alarcón de la Lastra C Nutr Cancer; 2013; 65(1):147-56. PubMed ID: 23368925 [TBL] [Abstract][Full Text] [Related]
11. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Chen A; Xu J; Johnson AC Oncogene; 2006 Jan; 25(2):278-87. PubMed ID: 16170359 [TBL] [Abstract][Full Text] [Related]
12. Hydroxytyrosol and Cytoprotection: A Projection for Clinical Interventions. Echeverría F; Ortiz M; Valenzuela R; Videla LA Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28452954 [TBL] [Abstract][Full Text] [Related]
13. Effects of trastuzumab on epidermal growth factor receptor-dependent and -independent human colon cancer cells. Kuwada SK; Scaife CL; Kuang J; Li X; Wong RF; Florell SR; Coffey RJ; Gray PD Int J Cancer; 2004 Mar; 109(2):291-301. PubMed ID: 14750183 [TBL] [Abstract][Full Text] [Related]
14. Extravirgin olive oil up-regulates CB₁ tumor suppressor gene in human colon cancer cells and in rat colon via epigenetic mechanisms. Di Francesco A; Falconi A; Di Germanio C; Micioni Di Bonaventura MV; Costa A; Caramuta S; Del Carlo M; Compagnone D; Dainese E; Cifani C; Maccarrone M; D'Addario C J Nutr Biochem; 2015 Mar; 26(3):250-8. PubMed ID: 25533906 [TBL] [Abstract][Full Text] [Related]
15. Cancer chemoprevention by hydroxytyrosol isolated from virgin olive oil through G1 cell cycle arrest and apoptosis. Fabiani R; De Bartolomeo A; Rosignoli P; Servili M; Montedoro GF; Morozzi G Eur J Cancer Prev; 2002 Aug; 11(4):351-8. PubMed ID: 12195161 [TBL] [Abstract][Full Text] [Related]
16. (-)-Epigallocatechin gallate downregulates EGF receptor via phosphorylation at Ser1046/1047 by p38 MAPK in colon cancer cells. Adachi S; Shimizu M; Shirakami Y; Yamauchi J; Natsume H; Matsushima-Nishiwaki R; To S; Weinstein IB; Moriwaki H; Kozawa O Carcinogenesis; 2009 Sep; 30(9):1544-52. PubMed ID: 19578043 [TBL] [Abstract][Full Text] [Related]
17. EphrinA5 suppresses colon cancer development by negatively regulating epidermal growth factor receptor stability. Wang TH; Chang JL; Ho JY; Wu HC; Chen TC FEBS J; 2012 Jan; 279(2):251-63. PubMed ID: 22074469 [TBL] [Abstract][Full Text] [Related]
18. Antitumor Perspectives of Oleuropein and Its Metabolite Hydroxytyrosol: Recent Updates. Imran M; Nadeem M; Gilani SA; Khan S; Sajid MW; Amir RM J Food Sci; 2018 Jul; 83(7):1781-1791. PubMed ID: 29928786 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of cell cycle progression by the hydroxytyrosol-cetuximab combination yields enhanced chemotherapeutic efficacy in colon cancer cells. Terzuoli E; Nannelli G; Frosini M; Giachetti A; Ziche M; Donnini S Oncotarget; 2017 Oct; 8(47):83207-83224. PubMed ID: 29137335 [TBL] [Abstract][Full Text] [Related]
20. Enhanced antitumor activity of anti-epidermal growth factor receptor monoclonal antibody IMC-C225 in combination with irinotecan (CPT-11) against human colorectal tumor xenografts. Prewett MC; Hooper AT; Bassi R; Ellis LM; Waksal HW; Hicklin DJ Clin Cancer Res; 2002 May; 8(5):994-1003. PubMed ID: 12006511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]